PDG81 EARLY HEALTH TECHNOLOGY ASSESSMENT (HTA): LESSONS LEARNED FROM A RUSSIAN BIOTECHNOLOGY COMPANY

Abstract

Authors

D. Tolkacheva V. Sokolova

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×